4.6 Article

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function

Reza Khosravan et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2010)

Letter Oncology

Pharmacokinetics of sunitinib in hemodialysis

H. Izzedine et al.

ANNALS OF ONCOLOGY (2009)

Article Urology & Nephrology

Association of CKD and Cancer Risk in Older People

Germaine Wong et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Medicine, General & Internal

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Robert J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Cancer incidence before and after kidney transplantation

Claire M. Vajdic et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Oncology

Global cancer statistics, 2002

DM Parkin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2005)

Article Cardiac & Cardiovascular Systems

Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals

LF Fried et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)